TY - JOUR AU - Parihar, M. G. J. K. S. PY - 2016 DA - 2016// TI - Glaucoma: the “black hole” of irreversible blindness JO - Med J Armed Forces India VL - 72 UR - https://doi.org/10.1016/j.mjafi.2015.12.001 DO - 10.1016/j.mjafi.2015.12.001 ID - Parihar2016 ER - TY - JOUR AU - Nordstrom, B. L. AU - Friedman, D. S. AU - Mozaffari, E. AU - Quigley, H. A. AU - Walker, A. M. PY - 2005 DA - 2005// TI - Persistence and adherence with topical glaucoma therapy JO - Am J Clin Nutr VL - 140 ID - Nordstrom2005 ER - TY - JOUR AU - Jutley, G. AU - Luk, S. M. H. AU - Dehabadi, M. H. AU - Francesca, M. PY - 2017 DA - 2017// TI - Management of glaucoma as a neurodegenerative disease JO - Neurodegener Dis Manag VL - 7 UR - https://doi.org/10.2217/nmt-2017-0004 DO - 10.2217/nmt-2017-0004 ID - Jutley2017 ER - TY - JOUR AU - Reardon, G. AU - Kotak, S. AU - Schwartz, G. F. PY - 2011 DA - 2011// TI - Objective assessment of compliance and persistence among patients treated for glaucoma and ocular hypertension: a systematic review JO - Patient Prefer Adherence VL - 5 UR - https://doi.org/10.2147/PPA.S23780 DO - 10.2147/PPA.S23780 ID - Reardon2011 ER - TY - JOUR AU - Iskedjian, M. AU - Covert, D. W. AU - Walker, J. H. PY - 2011 DA - 2011// TI - Persistence with prostaglandin agonist use with and without adjunctive therapy for glaucoma patients JO - Patient. VL - 4 UR - https://doi.org/10.2165/11539460-000000000-00000 DO - 10.2165/11539460-000000000-00000 ID - Iskedjian2011 ER - TY - JOUR AU - Kashiwagi, K. AU - Furuya, T. PY - 2014 DA - 2014// TI - Persistence with topical glaucoma therapy among newly diagnosed Japanese patients JO - Jpn J Ophthalmol VL - 58 UR - https://doi.org/10.1007/s10384-013-0284-2 DO - 10.1007/s10384-013-0284-2 ID - Kashiwagi2014 ER - TY - BOOK PY - 2018 DA - 2018// TI - Glaucoma treatment guideline ID - ref7 ER - TY - JOUR AU - Noecker, R. J. PY - 2006 DA - 2006// TI - The management of glaucoma and intraocular hypertension: current approaches and recent advances JO - Ther Clin Risk Manag VL - 2 UR - https://doi.org/10.2147/tcrm.2006.2.2.193 DO - 10.2147/tcrm.2006.2.2.193 ID - Noecker2006 ER - TY - JOUR AU - Aihara, M. AU - Adachi, M. AU - Matsuo, H. AU - Togano, T. AU - Fukuchi, T. AU - Sasaki, N. PY - 2017 DA - 2017// TI - Additive effects and safety of fixed combination therapy with 1% brinzolamide and 0.5% timolol versus 1% dorzolamide and 0.5% timolol in prostaglandin-treated glaucoma patients JO - Acta Ophthalmol VL - 95 UR - https://doi.org/10.1111/aos.13401 DO - 10.1111/aos.13401 ID - Aihara2017 ER - TY - JOUR AU - Cheng, J. AU - Cheng, S. AU - Gao, L. AU - Lu, G. AU - Wei, R. PY - 2012 DA - 2012// TI - Intraocular pressure-lowering effects of commonly used fixed-combination drugs with timolol: a systematic review and meta-analysis JO - PLoS One VL - 7 UR - https://doi.org/10.1371/journal.pone.0045079 DO - 10.1371/journal.pone.0045079 ID - Cheng2012 ER - TY - JOUR AU - Leung, V. C. AU - Jin, Y. -. P. AU - Hatch, W. AU - Mammo, Z. AU - Trope, G. E. AU - Buys, Y. M. PY - 2015 DA - 2015// TI - The relationship between sociodemographic factors and persistence with topical glaucoma medications JO - J Glaucoma VL - 24 UR - https://doi.org/10.1097/IJG.0000000000000081 DO - 10.1097/IJG.0000000000000081 ID - Leung2015 ER - TY - JOUR AU - Quek, D. T. AU - Ong, G. -. T. AU - Perera, S. A. AU - Lamoureux, E. L. AU - Aung, T. PY - 2011 DA - 2011// TI - Persistence of patients receiving topical glaucoma monotherapy in an Asian population JO - Arch Ophthalmol VL - 129 UR - https://doi.org/10.1001/archophthalmol.2010.345 DO - 10.1001/archophthalmol.2010.345 ID - Quek2011 ER - TY - JOUR AU - Hwang, D. -. K. AU - Liu, C. J. -. L. AU - Pu, C. -. Y. AU - Chou, Y. -. J. AU - Chou, P. PY - 2014 DA - 2014// TI - Persistence of topical glaucoma medication a nationwide population-based cohort study in Taiwan JO - JAMA Ophthalmol VL - 132 UR - https://doi.org/10.1001/jamaophthalmol.2014.3333 DO - 10.1001/jamaophthalmol.2014.3333 ID - Hwang2014 ER - TY - JOUR AU - Friedman, D. S. PY - 2009 DA - 2009// TI - Introduction: new insights on enhancing adherence to topical glaucoma JO - Ophthalmology. VL - 116 UR - https://doi.org/10.1016/j.ophtha.2009.06.026 DO - 10.1016/j.ophtha.2009.06.026 ID - Friedman2009 ER - TY - JOUR AU - Newman-Casey, P. A. AU - Robin, A. L. AU - Blachley, T. AU - Farris, K. AU - Heisler, M. AU - Resnicow, K. PY - 2015 DA - 2015// TI - The Most common barriers to Glaucoma medication adherence: a cross-sectional survey JO - Ophthalmology. VL - 122 UR - https://doi.org/10.1016/j.ophtha.2015.03.026 DO - 10.1016/j.ophtha.2015.03.026 ID - Newman-Casey2015 ER - TY - JOUR AU - Baudouin, C. AU - Liang, H. AU - Hamard, P. AU - Riancho, L. AU - Creuzot-Garcher, C. AU - Warnet, J. M. PY - 2008 DA - 2008// TI - The ocular surface of Glaucoma patients treated over the long term expresses inflammatory markers related to both T-helper 1 and T-helper 2 pathways JO - Ophthalmology. VL - 115 UR - https://doi.org/10.1016/j.ophtha.2007.01.036 DO - 10.1016/j.ophtha.2007.01.036 ID - Baudouin2008 ER - TY - JOUR AU - Skalicky, S. E. AU - Goldberg, I. AU - McCluskey, P. PY - 2012 DA - 2012// TI - Ocular surface disease and quality of life in patients with glaucoma JO - Am J Ophthalmol VL - 153 UR - https://doi.org/10.1016/j.ajo.2011.05.033 DO - 10.1016/j.ajo.2011.05.033 ID - Skalicky2012 ER - TY - JOUR AU - Barnebey, H. S. AU - Robin, A. L. PY - 2017 DA - 2017// TI - Adherence to fixed-combination versus unfixed travoprost 0.004%/timolol 0.5% for glaucoma or ocular hypertension: A randomized trial JO - Am J Ophthalmol. VL - 176 UR - https://doi.org/10.1016/j.ajo.2016.12.002 DO - 10.1016/j.ajo.2016.12.002 ID - Barnebey2017 ER - TY - STD TI - JMDC Inc. JMDC claim database 2019. https://www.jmdc.co.jp/en/pharma/database.html. Accessed 6 May 2019. UR - https://www.jmdc.co.jp/en/pharma/database.html ID - ref19 ER - TY - JOUR AU - Kimura, S. AU - Sato, T. AU - Ikeda, S. AU - Noda, M. AU - Nakayama, T. PY - 2010 DA - 2010// TI - Development of a database of health insurance claims: standardization of disease classifications and anonymous record linkage JO - J Epidemiol VL - 20 UR - https://doi.org/10.2188/jea.JE20090066 DO - 10.2188/jea.JE20090066 ID - Kimura2010 ER - TY - JOUR AU - Higginbotham, E. J. AU - Hansen, J. AU - Davis, E. J. AU - Walt, J. G. AU - Guckian, A. PY - 2009 DA - 2009// TI - Glaucoma medication persistence with a fixed combination versus multiple bottles JO - Curr Med Res Opin VL - 25 UR - https://doi.org/10.1185/03007990903260129 DO - 10.1185/03007990903260129 ID - Higginbotham2009 ER - TY - JOUR AU - Choudhari, N. S. AU - Pathak-ray, V. AU - Kaushik, S. AU - Vyas, P. AU - George, R. PY - 2017 DA - 2017// TI - Understanding practice patterns of glaucoma sub- specialists in India JO - Int J Opthalmol VL - 10 ID - Choudhari2017 ER - TY - JOUR AU - Coleman, A. L. AU - Lum, F. C. AU - Su, Z. AU - Gliklich, R. E. PY - 2016 DA - 2016// TI - Practice patterns and treatment changes for open-angle glaucoma : the RiGOR study JO - J Comp Eff Res VL - 5 UR - https://doi.org/10.2217/cer.15.57 DO - 10.2217/cer.15.57 ID - Coleman2016 ER - TY - JOUR AU - Goldshtein, I. AU - Shalev, V. AU - Zigman, N. PY - 2016 DA - 2016// TI - The Maccabi glaucoma study: treatment patterns and persistence with glaucoma therapy in a large Israeli health maintenance organization JO - J Glaucoma VL - 25 UR - https://doi.org/10.1097/IJG.0000000000000380 DO - 10.1097/IJG.0000000000000380 ID - Goldshtein2016 ER - TY - JOUR AU - Marquis, R. E. AU - Whitson, J. T. PY - 2005 DA - 2005// TI - Management of glaucoma: focus on pharmacological therapy JO - Drugs Aging VL - 22 UR - https://doi.org/10.2165/00002512-200522010-00001 DO - 10.2165/00002512-200522010-00001 ID - Marquis2005 ER - TY - JOUR AU - Whitson, J. T. PY - 2007 DA - 2007// TI - Glaucoma: a review of adjunctive therapy and new management strategies JO - Expert Opin Pharmacother VL - 8 UR - https://doi.org/10.1517/14656566.8.18.3237 DO - 10.1517/14656566.8.18.3237 ID - Whitson2007 ER - TY - JOUR AU - Kim, C. Y. AU - Park, K. H. AU - Ahn, J. AU - Ahn, M. AU - Cha, S. C. AU - Kim, H. S. PY - 2017 DA - 2017// TI - Treatment patterns and medication adherence of patients with glaucoma in South Korea JO - Br J Ophthalmol VL - 101 UR - https://doi.org/10.1136/bjophthalmol-2016-308505 DO - 10.1136/bjophthalmol-2016-308505 ID - Kim2017 ER - TY - JOUR AU - Robin, A. L. AU - Novack, G. D. AU - Covert, D. W. AU - Crockett, R. S. AU - Marcic, T. S. PY - 2007 DA - 2007// TI - Adherence in glaucoma: objective measurements of once-daily and adjunctive medication use JO - Am J Ophthalmol VL - 144 UR - https://doi.org/10.1016/j.ajo.2007.06.012 DO - 10.1016/j.ajo.2007.06.012 ID - Robin2007 ER - TY - BOOK PY - 2016 DA - 2016// TI - Asia Pacific glaucoma guidelines ID - ref29 ER - TY - JOUR AU - Lu, V. H. AU - Goldberg, I. AU - Lu, C. Y. PY - 2010 DA - 2010// TI - Use of glaucoma medications: state of the science and directions for observational research JO - Am J Ophthalmol VL - 150 UR - https://doi.org/10.1016/j.ajo.2010.05.005 DO - 10.1016/j.ajo.2010.05.005 ID - Lu2010 ER - TY - JOUR AU - Suissa, S. AU - Garbe, E. PY - 2007 DA - 2007// TI - Primer: administrative health databases in observational studies of drug effects — advantages and disadvantages JO - Nat Clin Pract VL - 3 UR - https://doi.org/10.1038/ncprheum0652 DO - 10.1038/ncprheum0652 ID - Suissa2007 ER -